1. Home
  2. BIRK vs HALO Comparison

BIRK vs HALO Comparison

Compare BIRK & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIRK
  • HALO
  • Stock Information
  • Founded
  • BIRK 1774
  • HALO 1998
  • Country
  • BIRK United Kingdom
  • HALO United States
  • Employees
  • BIRK N/A
  • HALO N/A
  • Industry
  • BIRK
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • BIRK
  • HALO Health Care
  • Exchange
  • BIRK Nasdaq
  • HALO Nasdaq
  • Market Cap
  • BIRK 8.8B
  • HALO 7.6B
  • IPO Year
  • BIRK 2023
  • HALO N/A
  • Fundamental
  • Price
  • BIRK $45.61
  • HALO $75.81
  • Analyst Decision
  • BIRK Strong Buy
  • HALO Buy
  • Analyst Count
  • BIRK 11
  • HALO 8
  • Target Price
  • BIRK $68.27
  • HALO $70.25
  • AVG Volume (30 Days)
  • BIRK 1.6M
  • HALO 1.8M
  • Earning Date
  • BIRK 08-14-2025
  • HALO 10-30-2025
  • Dividend Yield
  • BIRK N/A
  • HALO N/A
  • EPS Growth
  • BIRK 178.47
  • HALO 68.93
  • EPS
  • BIRK 1.92
  • HALO 4.37
  • Revenue
  • BIRK $2,380,334,704.00
  • HALO $1,178,672,000.00
  • Revenue This Year
  • BIRK $18.03
  • HALO $32.57
  • Revenue Next Year
  • BIRK $14.32
  • HALO $23.25
  • P/E Ratio
  • BIRK $23.78
  • HALO $17.40
  • Revenue Growth
  • BIRK 17.60
  • HALO 34.97
  • 52 Week Low
  • BIRK $40.56
  • HALO $42.01
  • 52 Week High
  • BIRK $62.66
  • HALO $77.60
  • Technical
  • Relative Strength Index (RSI)
  • BIRK 33.36
  • HALO 70.39
  • Support Level
  • BIRK $44.67
  • HALO $75.25
  • Resistance Level
  • BIRK $51.37
  • HALO $77.60
  • Average True Range (ATR)
  • BIRK 1.38
  • HALO 1.67
  • MACD
  • BIRK -0.55
  • HALO -0.36
  • Stochastic Oscillator
  • BIRK 11.44
  • HALO 70.66

About BIRK Birkenstock Holding plc

Birkenstock Holding PLC is a company that manufactures and sells footbed-based products, including sandals, closed-toe silhouettes, and other products, such as skincare and accessories, for everyday, leisure, and work. It sells its products through two main channels: business-to-business (B2B) which comprises sales made to established third-party store networks, and direct-to-consumer (DTC) which comprises sales made on globally owned online stores through the Birkenstock.com domain and sales made in Birkenstock retail stores. The company's reportable segments are based on its regional hubs and include: the Americas which is also its key revenue-generating segment; Europe; and Australia, Japan, India, China, and the United Arab Emirates (APMA).

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: